Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 26 Jan 2026 09:29 CET |
TITAN S.A. | Titan Launches Investor Roadshow for potential upcoming offering of €350 million expected senior unsecured notes. | 50101030 Cement | Other subject |
| 26 Jan 2026 07:00 CET |
BANQUP GROUP | Banqup secures additional shareholder funding, recalibrates covenants with Francisco Partners and signs an agreement for the sale of Baltic operations | 10101010 Computer Services | Other financial transaction |
| 26 Jan 2026 06:53 CET |
JENSEN-GROUP | Inkoop eigen aandelen, wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 26 Jan 2026 06:52 CET |
JENSEN-GROUP | Share buy-back, weekly update | 50204000 Machinery: Industrial | Other subject |
| 23 Jan 2026 18:30 CET |
UMICORE | Umicore - Transparantieverklaring van BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 23 Jan 2026 18:30 CET |
UMICORE | Umicore - Transparency notification by BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 23 Jan 2026 18:30 CET |
UMICORE | Umicore - Déclaration de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 23 Jan 2026 18:00 CET |
OXURION | Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC | 20103010 Biotechnology | Change in Capital |
| 23 Jan 2026 18:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC | 20103010 Biotechnology | Change in Capital |
| 23 Jan 2026 08:15 CET |
BEKAERT | Bekaert - Update on the Share Buyback Program and Liquidity Agreement | 55102010 Iron and Steel | Legal |
| 23 Jan 2026 08:15 CET |
BEKAERT | Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
| 23 Jan 2026 07:30 CET |
ONWARD MEDICAL | ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer | 20102010 Medical Equipment | - |
| 23 Jan 2026 07:00 CET |
BIOTALYS NV | Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production | 55201015 Fertilizers | - |
| 22 Jan 2026 18:00 CET |
HYBRID SOFTWARE GROUP PLC | Update on the share repurchase program | 10101015 Software | Share history |
| 22 Jan 2026 17:50 CET |
VIOHALCO | Publication relative aux notifications de transparence | 55102015 Metal Fabricating | Other subject |
| 22 Jan 2026 17:50 CET |
VIOHALCO | Publication of transparency notifications | 55102015 Metal Fabricating | Other subject |
| 22 Jan 2026 17:48 CET |
VIOHALCO | Nomination d’un nouveau Président et d’un nouveau Vice-Président du Conseil d’administration | 55102015 Metal Fabricating | Other subject |
| 22 Jan 2026 17:47 CET |
VIOHALCO | Appointment of new Chairman and new Vice-Chairman of the Board of Directors | 55102015 Metal Fabricating | Other subject |
| 22 Jan 2026 10:30 CET |
ONTEX GROUP | Ontex lanceert multi-liquid liner in Europa, afgestemd op de noden van vrouwen in perimenopauze en menopauze | 45201020 Personal Products | Other subject |
| 22 Jan 2026 10:30 CET |
ONTEX GROUP | Ontex launches multi-liquid liner in Europe, empowering women in perimenopause and menopause | 45201020 Personal Products | Other subject |
| 22 Jan 2026 07:30 CET |
ONWARD MEDICAL | ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement | 20102010 Medical Equipment | - |
| 21 Jan 2026 22:05 CET |
NYXOAH SA | Nyxoah Investit Dans l'Expansion De Sa Capacité De Production En Belgique Afin De Soutenir Sa Croissance Mondiale | 20102010 Medical Equipment | Other subject |
| 21 Jan 2026 22:05 CET |
NYXOAH SA | Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth | 20102010 Medical Equipment | Other subject |
| 21 Jan 2026 18:00 CET |
ION BEAM APPLICATIONS | IBA – TRANSPARENCY NOTIFICATION | 20102010 Medical Equipment | Legal |
| 21 Jan 2026 18:00 CET |
ION BEAM APPLICATIONS | IBA SA – NOTIFICATION TRANSPARENCE | 20102010 Medical Equipment | Legal |
| 21 Jan 2026 17:46 CET |
AEDIFICA | Aedifica NV/SA – Aedifica’s obtains approval from Belgian Competition Authority | 35102010 Health Care REITs | Takeover bids |
| 21 Jan 2026 07:40 CET |
OPTION | GEREGLEMENTEERDE INFORMATIE - De wedergeboorte van Option | 15101010 Telecommunications Equipment | Other subject |
| 21 Jan 2026 07:35 CET |
OPTION | REGULATED INFORMATION - The rebirth of Option | 15101010 Telecommunications Equipment | Other subject |
| 20 Jan 2026 18:30 CET |
UMICORE | Umicore - Déclaration de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 20 Jan 2026 18:30 CET |
UMICORE | Umicore - Transparency notification by BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 20 Jan 2026 18:30 CET |
UMICORE | Umicore - Transparantieverklaring van BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 20 Jan 2026 17:45 CET |
KINEPOLIS GROUP | Publication of a transparency notification | 40301010 Entertainment | Corporate life |
| 20 Jan 2026 17:45 CET |
KINEPOLIS GROUP | Publication relative à une notification de transparence | 40301010 Entertainment | Corporate life |
| 20 Jan 2026 17:45 CET |
KINEPOLIS GROUP | Openbaarmaking van een transparantiekennisgeving | 40301010 Entertainment | Corporate life |
| 20 Jan 2026 17:45 CET |
SOLVAY | Notifications de participation par Morgan Stanley | 55201000 Chemicals: Diversified | Corporate life |
| 20 Jan 2026 17:45 CET |
SOLVAY | Participatiemeldingen van Morgan Stanley | 55201000 Chemicals: Diversified | Corporate life |
| 20 Jan 2026 17:45 CET |
SOLVAY | Participation notifications by Morgan Stanley | 55201000 Chemicals: Diversified | Corporate life |
| 20 Jan 2026 08:25 CET |
TITAN S.A. | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 20 Jan 2026 08:24 CET |
TITAN S.A. | Share buyback programme | 50101030 Cement | Other subject |
| 20 Jan 2026 07:30 CET |
GIMV | Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy | 30202010 Asset Managers and Custodians | Other subject |
| 20 Jan 2026 07:30 CET |
GIMV | Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling | 30202010 Asset Managers and Custodians | Other subject |
| 20 Jan 2026 07:30 CET |
GIMV | Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy | 30202010 Asset Managers and Custodians | Other subject |
| 19 Jan 2026 21:44 CET |
HYLORIS | Hyloris Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets | 20103010 Biotechnology | Corporate life |
| 19 Jan 2026 18:11 CET |
GBL | GBL – Transacties op GBL-aandelen 19-01-2026 | 30202000 Diversified Financial Services | Other financial transaction |
| 19 Jan 2026 18:10 CET |
GBL | GBL – Transactions sur actions propres 19-01-2026 | 30202000 Diversified Financial Services | Other financial transaction |
| 19 Jan 2026 18:09 CET |
GBL | GBL – Transactions on GBL shares 19-01-2026 | 30202000 Diversified Financial Services | Other financial transaction |
| 19 Jan 2026 18:00 CET |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | Change in Capital |
| 19 Jan 2026 18:00 CET |
OXURION | Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie | 20103010 Biotechnology | Change in Capital |
| 19 Jan 2026 17:45 CET |
European Medical Solutions | 50 M EUR DE CHIFFRE D'AFFAIRES ANNUEL 2025 EN CROISSANCE ORGANIQUE DE +11% | 20103010 Biotechnology | Legal |
| 19 Jan 2026 08:00 CET |
OXURION | Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets | 20103010 Biotechnology | Legal |